Related Experiment Video
Updated: Jan 11, 2026

A Simple and Inexpensive Running Wheel Model for Progressive Resistance Training in Mice
Published on: April 28, 2022
Donepezil treatment, alone or combined with exercise, enhances skeletal muscle function in healthy and advanced aging
Nicholas J Ernst1, Edziu Franczak1,2, Julie Allen1,2
1Department of Cell Biology and Physiology, The University of Kansas Medical Center, Kansas City, Kansas, United States.
Abstract:
Reduced muscle mass and function are hallmarks of aging, increased frailty, and reduced resilience. There are no clinically approved interventions besides exercise to improve muscle quality and function in the elderly. We recently found that older participants with mild cognitive impairment (MCI) who took the acetylcholinesterase inhibitor donepezil (DON) had greater skeletal muscle mitochondrial respiratory capacity than nontreated counterparts. Here we tested whether DON treatment or DON + exercise on treadmill (EX) improved muscle and mitochondrial function in male and female mice that were young adult wild type (WT) or with an early aging phenotype [CDGH iron-sulfur domain 2 (Cisd2) knockout mice] (Cisd2KO; n = 10-12 total mice/strain) from 4 to 15 wk of age. In WT mice, DON improved screen hanging time at the midpoint and increased grip strength at the endpoint of the 11-wk study. Furthermore, DON increased nonresting energy expenditure and improved palmitate-dependent mitochondrial respiration in the gastrocnemius muscle in WT, while interacting with exercise to alter state 3 respiration in Cisd2KO gastrocnemius. DON + EX resulted in greater WT quadriceps mass and reduced endpoint beam walk slipping, whereas DON increased midpoint screen hang time and reduced endpoint beam slips in the Cisd2KO. Overall, this study provides preliminary evidence that cholinesterase inhibition partially benefits skeletal muscle strength and quality in young healthy mice, changes that are associated with improvements in mitochondrial respiration. However, cholinesterase inhibition had minimal effects in a model of advanced aging. Further research is needed to determine whether cholinesterase inhibitors can combat age-related muscle decline.NEW & NOTEWORTHY Aging is often accompanied by a decline in muscle mass and function, with limited effective treatments. The study provides novel insights into the potential of donepezil, an acetylcholinesterase medication primarily used for dementia, to improve skeletal muscle health and function.
Related Concept Videos
Alzheimer's Disease: Treatment
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Skeletal Muscle Relaxants: Therapeutic Uses
Pharmacodynamics in Geriatric Patients: Effects of Age
The Effect of Aging on Tissues

